These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 10572962)

  • 1. Re-establishing the long circulatory behaviour of poloxamine-coated particles after repeated intravenous administration: applications in cancer drug delivery and imaging.
    Moghimi SM
    Biochim Biophys Acta; 1999 Oct; 1472(1-2):399-403. PubMed ID: 10572962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single dose of intravenously injected poloxamine-coated long-circulating particles triggers macrophage clearance of subsequent doses in rats.
    Moghimi SM; Gray T
    Clin Sci (Lond); 1997 Oct; 93(4):371-9. PubMed ID: 9404230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the mononuclear phagocyte system by poloxamine 908: its implications for targeted drug delivery.
    Armstrong TI; Moghimi SM; Davis SS; Illum L
    Pharm Res; 1997 Nov; 14(11):1629-33. PubMed ID: 9434285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonging the circulation time and modifying the body distribution of intravenously injected polystyrene nanospheres by prior intravenous administration of poloxamine-908. A 'hepatic-blockade' event or manipulation of nanosphere surface in vivo?
    Moghimi SM
    Biochim Biophys Acta; 1997 Jul; 1336(1):1-6. PubMed ID: 9271243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coating particles with a block co-polymer (poloxamine-908) suppresses opsonization but permits the activity of dysopsonins in the serum.
    Moghimi SM; Muir IS; Illum L; Davis SS; Kolb-Bachofen V
    Biochim Biophys Acta; 1993 Nov; 1179(2):157-65. PubMed ID: 8218358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced hepatic clearance of intravenously administered sterically stabilized microspheres in zymosan-stimulated rats.
    Moghimi SM; Hedeman H; Christy NM; Illum L; Davis SS
    J Leukoc Biol; 1993 Dec; 54(6):513-7. PubMed ID: 8245702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An investigation of the filtration capacity and the fate of large filtered sterically-stabilized microspheres in rat spleen.
    Moghimi SM; Hedeman H; Muir IS; Illum L; Davis SS
    Biochim Biophys Acta; 1993 Jul; 1157(3):233-40. PubMed ID: 8323953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug delivery in poly(lactide-co-glycolide) nanoparticles surface modified with poloxamer 407 and poloxamine 908: in vitro characterisation and in vivo evaluation.
    Redhead HM; Davis SS; Illum L
    J Control Release; 2001 Feb; 70(3):353-63. PubMed ID: 11182205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification of the copolymers poloxamer 407 and poloxamine 908 can affect the physical and biological properties of surface modified nanospheres.
    Neal JC; Stolnik S; Garnett MC; Davis SS; Illum L
    Pharm Res; 1998 Feb; 15(2):318-24. PubMed ID: 9523321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-time evidence of surface modification at polystyrene lattices by poloxamine 908 in the presence of serum: in vivo conversion of macrophage-prone nanoparticles to stealth entities by poloxamine 908.
    Moghimi SM; Pavey KD; Hunter AC
    FEBS Lett; 2003 Jul; 547(1-3):177-82. PubMed ID: 12860409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of splenic congestion associated with haemolytic anaemia on filtration of 'spleen-homing' microspheres.
    Moghimi SM; Hedeman H; Illum L; Davis SS
    Clin Sci (Lond); 1993 Jun; 84(6):605-9. PubMed ID: 8334806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recognition and clearance of methoxypoly(ethyleneglycol)2000-grafted liposomes by macrophages with enhanced phagocytic capacity. Implications in experimental and clinical oncology.
    Laverman P; Carstens MG; Storm G; Moghimi SM
    Biochim Biophys Acta; 2001 Jun; 1526(3):227-9. PubMed ID: 11410330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polystyrene-poly (ethylene glycol) (PS-PEG2000) particles as model systems for site specific drug delivery. 2. The effect of PEG surface density on the in vitro cell interaction and in vivo biodistribution.
    Dunn SE; Brindley A; Davis SS; Davies MC; Illum L
    Pharm Res; 1994 Jul; 11(7):1016-22. PubMed ID: 7937542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concentration dependent structural ordering of poloxamine 908 on polystyrene nanoparticles and their modulatory role on complement consumption.
    Al-Hanbali O; Rutt KJ; Sarker DK; Hunter AC; Moghimi SM
    J Nanosci Nanotechnol; 2006; 6(9-10):3126-33. PubMed ID: 17048527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro displacement by rat serum of adsorbed radiolabeled poloxamer and poloxamine copolymers from model and biodegradable nanospheres.
    Neal JC; Stolnik S; Schacht E; Kenawy ER; Garnett MC; Davis SS; Illum L
    J Pharm Sci; 1998 Oct; 87(10):1242-8. PubMed ID: 9758684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phagocytic uptake and cytotoxicity of solid lipid nanoparticles (SLN) sterically stabilized with poloxamine 908 and poloxamer 407.
    Müller RH; Maassen S; Weyhers H; Mehnert W
    J Drug Target; 1996; 4(3):161-70. PubMed ID: 8959488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of poly(hydroxyethyl-l-asparagine)-coated liposomes is superior over that of PEG-coated liposomes at low lipid dose and upon repeated administration.
    Romberg B; Oussoren C; Snel CJ; Carstens MG; Hennink WE; Storm G
    Biochim Biophys Acta; 2007 Mar; 1768(3):737-43. PubMed ID: 17223070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of the surfactant concentration on the body distribution of nanoparticles.
    Araujo L; Löbenberg R; Kreuter J
    J Drug Target; 1999; 6(5):373-85. PubMed ID: 10342385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of the surface properties of low contact angle surfactants on the body distribution of 14C-poly(methyl methacrylate) nanoparticles.
    Tröster SD; Kreuter J
    J Microencapsul; 1992; 9(1):19-28. PubMed ID: 1613640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein adsorption patterns on poloxamer- and poloxamine-stabilized solid lipid nanoparticles (SLN).
    Göppert TM; Müller RH
    Eur J Pharm Biopharm; 2005 Aug; 60(3):361-72. PubMed ID: 15996577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.